Global GLP-1 for Diabetes Market Growth 2023-2029

February 2023 | 97 pages | ID: GCAD56813281EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

LPI (LP Information)' newest research report, the “GLP-1 for Diabetes Industry Forecast” looks at past sales and reviews total world GLP-1 for Diabetes sales in 2022, providing a comprehensive analysis by region and market sector of projected GLP-1 for Diabetes sales for 2023 through 2029. With GLP-1 for Diabetes sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world GLP-1 for Diabetes industry.

This Insight Report provides a comprehensive analysis of the global GLP-1 for Diabetes landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on GLP-1 for Diabetes portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global GLP-1 for Diabetes market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for GLP-1 for Diabetes and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global GLP-1 for Diabetes.

The global GLP-1 for Diabetes market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for GLP-1 for Diabetes is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for GLP-1 for Diabetes is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for GLP-1 for Diabetes is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key GLP-1 for Diabetes players cover Novo Nordisk, AstraZeneca, Eli Lily, GSK, Sanofi, Bristol-Myers Squibb and Amylin, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of GLP-1 for Diabetes market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type

• Injection
• Oral Agent

Segmentation by application

• Woman
• Man

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Novo Nordisk
• AstraZeneca
• Eli Lily
• GSK
• Sanofi
• Bristol-Myers Squibb
• Amylin

Key Questions Addressed in this Report

What is the 10-year outlook for the global GLP-1 for Diabetes market?

What factors are driving GLP-1 for Diabetes market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do GLP-1 for Diabetes market opportunities vary by end market size?

How does GLP-1 for Diabetes break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global GLP-1 for Diabetes Annual Sales 2018-2029
  2.1.2 World Current & Future Analysis for GLP-1 for Diabetes by Geographic Region, 2018, 2022 & 2029
  2.1.3 World Current & Future Analysis for GLP-1 for Diabetes by Country/Region, 2018, 2022 & 2029
2.2 GLP-1 for Diabetes Segment by Type
  2.2.1 Injection
  2.2.2 Oral Agent
2.3 GLP-1 for Diabetes Sales by Type
  2.3.1 Global GLP-1 for Diabetes Sales Market Share by Type (2018-2023)
  2.3.2 Global GLP-1 for Diabetes Revenue and Market Share by Type (2018-2023)
  2.3.3 Global GLP-1 for Diabetes Sale Price by Type (2018-2023)
2.4 GLP-1 for Diabetes Segment by Application
  2.4.1 Woman
  2.4.2 Man
2.5 GLP-1 for Diabetes Sales by Application
  2.5.1 Global GLP-1 for Diabetes Sale Market Share by Application (2018-2023)
  2.5.2 Global GLP-1 for Diabetes Revenue and Market Share by Application (2018-2023)
  2.5.3 Global GLP-1 for Diabetes Sale Price by Application (2018-2023)

3 GLOBAL GLP-1 FOR DIABETES BY COMPANY

3.1 Global GLP-1 for Diabetes Breakdown Data by Company
  3.1.1 Global GLP-1 for Diabetes Annual Sales by Company (2018-2023)
  3.1.2 Global GLP-1 for Diabetes Sales Market Share by Company (2018-2023)
3.2 Global GLP-1 for Diabetes Annual Revenue by Company (2018-2023)
  3.2.1 Global GLP-1 for Diabetes Revenue by Company (2018-2023)
  3.2.2 Global GLP-1 for Diabetes Revenue Market Share by Company (2018-2023)
3.3 Global GLP-1 for Diabetes Sale Price by Company
3.4 Key Manufacturers GLP-1 for Diabetes Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers GLP-1 for Diabetes Product Location Distribution
  3.4.2 Players GLP-1 for Diabetes Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 WORLD HISTORIC REVIEW FOR GLP-1 FOR DIABETES BY GEOGRAPHIC REGION

4.1 World Historic GLP-1 for Diabetes Market Size by Geographic Region (2018-2023)
  4.1.1 Global GLP-1 for Diabetes Annual Sales by Geographic Region (2018-2023)
  4.1.2 Global GLP-1 for Diabetes Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic GLP-1 for Diabetes Market Size by Country/Region (2018-2023)
  4.2.1 Global GLP-1 for Diabetes Annual Sales by Country/Region (2018-2023)
  4.2.2 Global GLP-1 for Diabetes Annual Revenue by Country/Region (2018-2023)
4.3 Americas GLP-1 for Diabetes Sales Growth
4.4 APAC GLP-1 for Diabetes Sales Growth
4.5 Europe GLP-1 for Diabetes Sales Growth
4.6 Middle East & Africa GLP-1 for Diabetes Sales Growth

5 AMERICAS

5.1 Americas GLP-1 for Diabetes Sales by Country
  5.1.1 Americas GLP-1 for Diabetes Sales by Country (2018-2023)
  5.1.2 Americas GLP-1 for Diabetes Revenue by Country (2018-2023)
5.2 Americas GLP-1 for Diabetes Sales by Type
5.3 Americas GLP-1 for Diabetes Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC GLP-1 for Diabetes Sales by Region
  6.1.1 APAC GLP-1 for Diabetes Sales by Region (2018-2023)
  6.1.2 APAC GLP-1 for Diabetes Revenue by Region (2018-2023)
6.2 APAC GLP-1 for Diabetes Sales by Type
6.3 APAC GLP-1 for Diabetes Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe GLP-1 for Diabetes by Country
  7.1.1 Europe GLP-1 for Diabetes Sales by Country (2018-2023)
  7.1.2 Europe GLP-1 for Diabetes Revenue by Country (2018-2023)
7.2 Europe GLP-1 for Diabetes Sales by Type
7.3 Europe GLP-1 for Diabetes Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa GLP-1 for Diabetes by Country
  8.1.1 Middle East & Africa GLP-1 for Diabetes Sales by Country (2018-2023)
  8.1.2 Middle East & Africa GLP-1 for Diabetes Revenue by Country (2018-2023)
8.2 Middle East & Africa GLP-1 for Diabetes Sales by Type
8.3 Middle East & Africa GLP-1 for Diabetes Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of GLP-1 for Diabetes
10.3 Manufacturing Process Analysis of GLP-1 for Diabetes
10.4 Industry Chain Structure of GLP-1 for Diabetes

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 GLP-1 for Diabetes Distributors
11.3 GLP-1 for Diabetes Customer

12 WORLD FORECAST REVIEW FOR GLP-1 FOR DIABETES BY GEOGRAPHIC REGION

12.1 Global GLP-1 for Diabetes Market Size Forecast by Region
  12.1.1 Global GLP-1 for Diabetes Forecast by Region (2024-2029)
  12.1.2 Global GLP-1 for Diabetes Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global GLP-1 for Diabetes Forecast by Type
12.7 Global GLP-1 for Diabetes Forecast by Application

13 KEY PLAYERS ANALYSIS

13.1 Novo Nordisk
  13.1.1 Novo Nordisk Company Information
  13.1.2 Novo Nordisk GLP-1 for Diabetes Product Portfolios and Specifications
  13.1.3 Novo Nordisk GLP-1 for Diabetes Sales, Revenue, Price and Gross Margin (2018-2023)
  13.1.4 Novo Nordisk Main Business Overview
  13.1.5 Novo Nordisk Latest Developments
13.2 AstraZeneca
  13.2.1 AstraZeneca Company Information
  13.2.2 AstraZeneca GLP-1 for Diabetes Product Portfolios and Specifications
  13.2.3 AstraZeneca GLP-1 for Diabetes Sales, Revenue, Price and Gross Margin (2018-2023)
  13.2.4 AstraZeneca Main Business Overview
  13.2.5 AstraZeneca Latest Developments
13.3 Eli Lily
  13.3.1 Eli Lily Company Information
  13.3.2 Eli Lily GLP-1 for Diabetes Product Portfolios and Specifications
  13.3.3 Eli Lily GLP-1 for Diabetes Sales, Revenue, Price and Gross Margin (2018-2023)
  13.3.4 Eli Lily Main Business Overview
  13.3.5 Eli Lily Latest Developments
13.4 GSK
  13.4.1 GSK Company Information
  13.4.2 GSK GLP-1 for Diabetes Product Portfolios and Specifications
  13.4.3 GSK GLP-1 for Diabetes Sales, Revenue, Price and Gross Margin (2018-2023)
  13.4.4 GSK Main Business Overview
  13.4.5 GSK Latest Developments
13.5 Sanofi
  13.5.1 Sanofi Company Information
  13.5.2 Sanofi GLP-1 for Diabetes Product Portfolios and Specifications
  13.5.3 Sanofi GLP-1 for Diabetes Sales, Revenue, Price and Gross Margin (2018-2023)
  13.5.4 Sanofi Main Business Overview
  13.5.5 Sanofi Latest Developments
13.6 Bristol-Myers Squibb
  13.6.1 Bristol-Myers Squibb Company Information
  13.6.2 Bristol-Myers Squibb GLP-1 for Diabetes Product Portfolios and Specifications
  13.6.3 Bristol-Myers Squibb GLP-1 for Diabetes Sales, Revenue, Price and Gross Margin (2018-2023)
  13.6.4 Bristol-Myers Squibb Main Business Overview
  13.6.5 Bristol-Myers Squibb Latest Developments
13.7 Amylin
  13.7.1 Amylin Company Information
  13.7.2 Amylin GLP-1 for Diabetes Product Portfolios and Specifications
  13.7.3 Amylin GLP-1 for Diabetes Sales, Revenue, Price and Gross Margin (2018-2023)
  13.7.4 Amylin Main Business Overview
  13.7.5 Amylin Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. GLP-1 for Diabetes Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. GLP-1 for Diabetes Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Injection
Table 4. Major Players of Oral Agent
Table 5. Global GLP-1 for Diabetes Sales by Type (2018-2023) & (K Units)
Table 6. Global GLP-1 for Diabetes Sales Market Share by Type (2018-2023)
Table 7. Global GLP-1 for Diabetes Revenue by Type (2018-2023) & ($ million)
Table 8. Global GLP-1 for Diabetes Revenue Market Share by Type (2018-2023)
Table 9. Global GLP-1 for Diabetes Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global GLP-1 for Diabetes Sales by Application (2018-2023) & (K Units)
Table 11. Global GLP-1 for Diabetes Sales Market Share by Application (2018-2023)
Table 12. Global GLP-1 for Diabetes Revenue by Application (2018-2023)
Table 13. Global GLP-1 for Diabetes Revenue Market Share by Application (2018-2023)
Table 14. Global GLP-1 for Diabetes Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global GLP-1 for Diabetes Sales by Company (2018-2023) & (K Units)
Table 16. Global GLP-1 for Diabetes Sales Market Share by Company (2018-2023)
Table 17. Global GLP-1 for Diabetes Revenue by Company (2018-2023) ($ Millions)
Table 18. Global GLP-1 for Diabetes Revenue Market Share by Company (2018-2023)
Table 19. Global GLP-1 for Diabetes Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers GLP-1 for Diabetes Producing Area Distribution and Sales Area
Table 21. Players GLP-1 for Diabetes Products Offered
Table 22. GLP-1 for Diabetes Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global GLP-1 for Diabetes Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global GLP-1 for Diabetes Sales Market Share Geographic Region (2018-2023)
Table 27. Global GLP-1 for Diabetes Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global GLP-1 for Diabetes Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global GLP-1 for Diabetes Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global GLP-1 for Diabetes Sales Market Share by Country/Region (2018-2023)
Table 31. Global GLP-1 for Diabetes Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global GLP-1 for Diabetes Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas GLP-1 for Diabetes Sales by Country (2018-2023) & (K Units)
Table 34. Americas GLP-1 for Diabetes Sales Market Share by Country (2018-2023)
Table 35. Americas GLP-1 for Diabetes Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas GLP-1 for Diabetes Revenue Market Share by Country (2018-2023)
Table 37. Americas GLP-1 for Diabetes Sales by Type (2018-2023) & (K Units)
Table 38. Americas GLP-1 for Diabetes Sales by Application (2018-2023) & (K Units)
Table 39. APAC GLP-1 for Diabetes Sales by Region (2018-2023) & (K Units)
Table 40. APAC GLP-1 for Diabetes Sales Market Share by Region (2018-2023)
Table 41. APAC GLP-1 for Diabetes Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC GLP-1 for Diabetes Revenue Market Share by Region (2018-2023)
Table 43. APAC GLP-1 for Diabetes Sales by Type (2018-2023) & (K Units)
Table 44. APAC GLP-1 for Diabetes Sales by Application (2018-2023) & (K Units)
Table 45. Europe GLP-1 for Diabetes Sales by Country (2018-2023) & (K Units)
Table 46. Europe GLP-1 for Diabetes Sales Market Share by Country (2018-2023)
Table 47. Europe GLP-1 for Diabetes Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe GLP-1 for Diabetes Revenue Market Share by Country (2018-2023)
Table 49. Europe GLP-1 for Diabetes Sales by Type (2018-2023) & (K Units)
Table 50. Europe GLP-1 for Diabetes Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa GLP-1 for Diabetes Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa GLP-1 for Diabetes Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa GLP-1 for Diabetes Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa GLP-1 for Diabetes Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa GLP-1 for Diabetes Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa GLP-1 for Diabetes Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of GLP-1 for Diabetes
Table 58. Key Market Challenges & Risks of GLP-1 for Diabetes
Table 59. Key Industry Trends of GLP-1 for Diabetes
Table 60. GLP-1 for Diabetes Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. GLP-1 for Diabetes Distributors List
Table 63. GLP-1 for Diabetes Customer List
Table 64. Global GLP-1 for Diabetes Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global GLP-1 for Diabetes Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas GLP-1 for Diabetes Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas GLP-1 for Diabetes Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC GLP-1 for Diabetes Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC GLP-1 for Diabetes Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe GLP-1 for Diabetes Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe GLP-1 for Diabetes Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa GLP-1 for Diabetes Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa GLP-1 for Diabetes Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global GLP-1 for Diabetes Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global GLP-1 for Diabetes Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global GLP-1 for Diabetes Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global GLP-1 for Diabetes Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Novo Nordisk Basic Information, GLP-1 for Diabetes Manufacturing Base, Sales Area and Its Competitors
Table 79. Novo Nordisk GLP-1 for Diabetes Product Portfolios and Specifications
Table 80. Novo Nordisk GLP-1 for Diabetes Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. Novo Nordisk Main Business
Table 82. Novo Nordisk Latest Developments
Table 83. AstraZeneca Basic Information, GLP-1 for Diabetes Manufacturing Base, Sales Area and Its Competitors
Table 84. AstraZeneca GLP-1 for Diabetes Product Portfolios and Specifications
Table 85. AstraZeneca GLP-1 for Diabetes Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. AstraZeneca Main Business
Table 87. AstraZeneca Latest Developments
Table 88. Eli Lily Basic Information, GLP-1 for Diabetes Manufacturing Base, Sales Area and Its Competitors
Table 89. Eli Lily GLP-1 for Diabetes Product Portfolios and Specifications
Table 90. Eli Lily GLP-1 for Diabetes Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. Eli Lily Main Business
Table 92. Eli Lily Latest Developments
Table 93. GSK Basic Information, GLP-1 for Diabetes Manufacturing Base, Sales Area and Its Competitors
Table 94. GSK GLP-1 for Diabetes Product Portfolios and Specifications
Table 95. GSK GLP-1 for Diabetes Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 96. GSK Main Business
Table 97. GSK Latest Developments
Table 98. Sanofi Basic Information, GLP-1 for Diabetes Manufacturing Base, Sales Area and Its Competitors
Table 99. Sanofi GLP-1 for Diabetes Product Portfolios and Specifications
Table 100. Sanofi GLP-1 for Diabetes Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 101. Sanofi Main Business
Table 102. Sanofi Latest Developments
Table 103. Bristol-Myers Squibb Basic Information, GLP-1 for Diabetes Manufacturing Base, Sales Area and Its Competitors
Table 104. Bristol-Myers Squibb GLP-1 for Diabetes Product Portfolios and Specifications
Table 105. Bristol-Myers Squibb GLP-1 for Diabetes Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 106. Bristol-Myers Squibb Main Business
Table 107. Bristol-Myers Squibb Latest Developments
Table 108. Amylin Basic Information, GLP-1 for Diabetes Manufacturing Base, Sales Area and Its Competitors
Table 109. Amylin GLP-1 for Diabetes Product Portfolios and Specifications
Table 110. Amylin GLP-1 for Diabetes Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 111. Amylin Main Business
Table 112. Amylin Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of GLP-1 for Diabetes
Figure 2. GLP-1 for Diabetes Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global GLP-1 for Diabetes Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global GLP-1 for Diabetes Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. GLP-1 for Diabetes Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Injection
Figure 10. Product Picture of Oral Agent
Figure 11. Global GLP-1 for Diabetes Sales Market Share by Type in 2022
Figure 12. Global GLP-1 for Diabetes Revenue Market Share by Type (2018-2023)
Figure 13. GLP-1 for Diabetes Consumed in Woman
Figure 14. Global GLP-1 for Diabetes Market: Woman (2018-2023) & (K Units)
Figure 15. GLP-1 for Diabetes Consumed in Man
Figure 16. Global GLP-1 for Diabetes Market: Man (2018-2023) & (K Units)
Figure 17. Global GLP-1 for Diabetes Sales Market Share by Application (2022)
Figure 18. Global GLP-1 for Diabetes Revenue Market Share by Application in 2022
Figure 19. GLP-1 for Diabetes Sales Market by Company in 2022 (K Units)
Figure 20. Global GLP-1 for Diabetes Sales Market Share by Company in 2022
Figure 21. GLP-1 for Diabetes Revenue Market by Company in 2022 ($ Million)
Figure 22. Global GLP-1 for Diabetes Revenue Market Share by Company in 2022
Figure 23. Global GLP-1 for Diabetes Sales Market Share by Geographic Region (2018-2023)
Figure 24. Global GLP-1 for Diabetes Revenue Market Share by Geographic Region in 2022
Figure 25. Americas GLP-1 for Diabetes Sales 2018-2023 (K Units)
Figure 26. Americas GLP-1 for Diabetes Revenue 2018-2023 ($ Millions)
Figure 27. APAC GLP-1 for Diabetes Sales 2018-2023 (K Units)
Figure 28. APAC GLP-1 for Diabetes Revenue 2018-2023 ($ Millions)
Figure 29. Europe GLP-1 for Diabetes Sales 2018-2023 (K Units)
Figure 30. Europe GLP-1 for Diabetes Revenue 2018-2023 ($ Millions)
Figure 31. Middle East & Africa GLP-1 for Diabetes Sales 2018-2023 (K Units)
Figure 32. Middle East & Africa GLP-1 for Diabetes Revenue 2018-2023 ($ Millions)
Figure 33. Americas GLP-1 for Diabetes Sales Market Share by Country in 2022
Figure 34. Americas GLP-1 for Diabetes Revenue Market Share by Country in 2022
Figure 35. Americas GLP-1 for Diabetes Sales Market Share by Type (2018-2023)
Figure 36. Americas GLP-1 for Diabetes Sales Market Share by Application (2018-2023)
Figure 37. United States GLP-1 for Diabetes Revenue Growth 2018-2023 ($ Millions)
Figure 38. Canada GLP-1 for Diabetes Revenue Growth 2018-2023 ($ Millions)
Figure 39. Mexico GLP-1 for Diabetes Revenue Growth 2018-2023 ($ Millions)
Figure 40. Brazil GLP-1 for Diabetes Revenue Growth 2018-2023 ($ Millions)
Figure 41. APAC GLP-1 for Diabetes Sales Market Share by Region in 2022
Figure 42. APAC GLP-1 for Diabetes Revenue Market Share by Regions in 2022
Figure 43. APAC GLP-1 for Diabetes Sales Market Share by Type (2018-2023)
Figure 44. APAC GLP-1 for Diabetes Sales Market Share by Application (2018-2023)
Figure 45. China GLP-1 for Diabetes Revenue Growth 2018-2023 ($ Millions)
Figure 46. Japan GLP-1 for Diabetes Revenue Growth 2018-2023 ($ Millions)
Figure 47. South Korea GLP-1 for Diabetes Revenue Growth 2018-2023 ($ Millions)
Figure 48. Southeast Asia GLP-1 for Diabetes Revenue Growth 2018-2023 ($ Millions)
Figure 49. India GLP-1 for Diabetes Revenue Growth 2018-2023 ($ Millions)
Figure 50. Australia GLP-1 for Diabetes Revenue Growth 2018-2023 ($ Millions)
Figure 51. China Taiwan GLP-1 for Diabetes Revenue Growth 2018-2023 ($ Millions)
Figure 52. Europe GLP-1 for Diabetes Sales Market Share by Country in 2022
Figure 53. Europe GLP-1 for Diabetes Revenue Market Share by Country in 2022
Figure 54. Europe GLP-1 for Diabetes Sales Market Share by Type (2018-2023)
Figure 55. Europe GLP-1 for Diabetes Sales Market Share by Application (2018-2023)
Figure 56. Germany GLP-1 for Diabetes Revenue Growth 2018-2023 ($ Millions)
Figure 57. France GLP-1 for Diabetes Revenue Growth 2018-2023 ($ Millions)
Figure 58. UK GLP-1 for Diabetes Revenue Growth 2018-2023 ($ Millions)
Figure 59. Italy GLP-1 for Diabetes Revenue Growth 2018-2023 ($ Millions)
Figure 60. Russia GLP-1 for Diabetes Revenue Growth 2018-2023 ($ Millions)
Figure 61. Middle East & Africa GLP-1 for Diabetes Sales Market Share by Country in 2022
Figure 62. Middle East & Africa GLP-1 for Diabetes Revenue Market Share by Country in 2022
Figure 63. Middle East & Africa GLP-1 for Diabetes Sales Market Share by Type (2018-2023)
Figure 64. Middle East & Africa GLP-1 for Diabetes Sales Market Share by Application (2018-2023)
Figure 65. Egypt GLP-1 for Diabetes Revenue Growth 2018-2023 ($ Millions)
Figure 66. South Africa GLP-1 for Diabetes Revenue Growth 2018-2023 ($ Millions)
Figure 67. Israel GLP-1 for Diabetes Revenue Growth 2018-2023 ($ Millions)
Figure 68. Turkey GLP-1 for Diabetes Revenue Growth 2018-2023 ($ Millions)
Figure 69. GCC Country GLP-1 for Diabetes Revenue Growth 2018-2023 ($ Millions)
Figure 70. Manufacturing Cost Structure Analysis of GLP-1 for Diabetes in 2022
Figure 71. Manufacturing Process Analysis of GLP-1 for Diabetes
Figure 72. Industry Chain Structure of GLP-1 for Diabetes
Figure 73. Channels of Distribution
Figure 74. Global GLP-1 for Diabetes Sales Market Forecast by Region (2024-2029)
Figure 75. Global GLP-1 for Diabetes Revenue Market Share Forecast by Region (2024-2029)
Figure 76. Global GLP-1 for Diabetes Sales Market Share Forecast by Type (2024-2029)
Figure 77. Global GLP-1 for Diabetes Revenue Market Share Forecast by Type (2024-2029)
Figure 78. Global GLP-1 for Diabetes Sales Market Share Forecast by Application (2024-2029)
Figure 79. Global GLP-1 for Diabetes Revenue Market Share Forecast by Application (2024-2029)